Agneta Zickert Selected Research

Therapeutics

1/2019	Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
1/2019	The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus.
4/2017	Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus.
1/2015	Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.
1/2009	Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agneta Zickert Research Topics

Disease

20	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2009
12	Lupus Nephritis 01/2021 - 01/2009
7	Nephritis 01/2020 - 01/2009
3	Autoimmune Diseases (Autoimmune Disease) 02/2019 - 02/2012
2	Thrombosis (Thrombus) 06/2022 - 07/2021
2	Chronic Disease (Chronic Diseases) 01/2019 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Fatigue 01/2019 - 04/2017
2	Venous Thrombosis (Deep-Vein Thrombosis) 06/2013 - 03/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2022
1	Venous Thromboembolism 07/2021
1	Albuminuria 01/2019
1	Arthritis (Polyarthritis) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Pain (Aches) 04/2017
1	Leukopenia 01/2017
1	Systemic Scleroderma (Systemic Sclerosis) 01/2017
1	Lymphopenia (Lymphocytopenia) 01/2017
1	Rheumatoid Arthritis 08/2015
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 04/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2015
1	Glomerulonephritis 01/2015
1	Vascular Diseases (Vascular Disease) 06/2013
1	Heart Diseases (Heart Disease) 03/2013
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2013
1	Atypical Hemolytic Uremic Syndrome 01/2011
1	Kidney Diseases (Kidney Disease) 01/2011

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 06/2022 - 01/2009
7	AutoantibodiesIBA 01/2022 - 01/2009
5	Antiphospholipid AntibodiesIBA 06/2022 - 06/2013
5	belimumabIBA 05/2020 - 04/2017
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
3	HLA-DRB1 Chains (HLA DRB1)IBA 06/2022 - 04/2015
3	Rituximab (Mabthera)FDA Link 01/2021 - 05/2013
3	CreatinineIBA 01/2020 - 04/2015
3	Complement System Proteins (Complement)IBA 01/2019 - 01/2011
3	InterferonsIBA 01/2019 - 01/2016
2	Prothrombin (Factor II)IBA 06/2022 - 07/2021
2	CytokinesIBA 05/2020 - 01/2017
2	Antigen-Antibody Complex (Immune Complex)IBA 11/2019 - 10/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2017 - 01/2017
2	Phospholipids (Phosphatides)FDA LinkGeneric 04/2015 - 03/2013
1	Cardiolipins (Cardiolipin)IBA 06/2022
1	PhosphatidylserinesIBA 06/2022
1	Immunoglobulin A (IgA)IBA 07/2021
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	anti-dsDNA autoantibodyIBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	Histones (Histone)IBA 11/2019
1	Interferon Type IIBA 01/2019
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019
1	ametantrone (HAQ)IBA 01/2019
1	Stem Cell FactorIBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Platelet-Derived Growth FactorIBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Serum AlbuminIBA 01/2018
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	AlbuminsIBA 01/2018
1	Prostaglandins AIBA 04/2017
1	Biological ProductsIBA 04/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017
1	Interferon LambdaIBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 02/2015
1	Interleukin-23 (Interleukin 23)IBA 02/2015
1	B-Cell Activating FactorIBA 01/2015
1	LigandsIBA 01/2015
1	HLA-DRB1*04 antigenIBA 06/2013
1	Immunoglobulin G (IgG)IBA 03/2013
1	Immunoglobulin M (IgM)IBA 03/2013
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 01/2013
1	HMGB1 Protein (HMG1)IBA 02/2012
1	Proteins (Proteins, Gene)FDA Link 02/2012
1	Complement Factor H (Factor H)IBA 01/2011
1	Complement Inactivating AgentsIBA 01/2011
1	C-Reactive ProteinIBA 01/2009

Therapy/Procedure

5	Therapeutics 01/2019 - 01/2009
1	Aftercare (After-Treatment) 02/2015